Skip to main content
SpringerLink
Log in

Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria

  • Notes
  • Ciprofloxacin: Clinical Experience
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Van Caekenberthe, D. L., Stefaan, R., Pattyn, S. R.: In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substitutued quinoline derivatives. Antimicrobial Agents and Chemotherapy 1984, 25: 518–521.

    PubMed  Google Scholar 

  2. Wise, R., Andrews, J. M., Edwards, L. J.: In vitro activity of Bay 0 9867, a new quinoline derivative, compared with that of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559–564.

    PubMed  Google Scholar 

  3. King, A., Shannon, K., Phillips, I.: The in vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. Journal of Antimicrobial Chemotherapy 1985, 15: 551–558.

    PubMed  Google Scholar 

  4. Gonzalez, M. A., Uribe, F., Duran, Moisen, S., Pichardo Fuster, A., Selen, A., Welling, P. G., Painter, B.: Multiple dose pharmacokinetics and safety of ciprofloxacin in normal volunteers. Antimicrobial Agents and Chemotherapy 1984, 26: 741–744.

    PubMed  Google Scholar 

  5. Höffken, G., Lode, H., Prinzing, C., Borner, K., Koeppe, P.: Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrobial Agents and Chemotherapy 1985, 27: 375–379.

    PubMed  Google Scholar 

  6. Crump, B., Wise, R., Dent, J.: Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1983, 23: 784–786.

    PubMed  Google Scholar 

  7. Guibert, J., Acar, J. F., Justin, C., Kitzis, M. D.: Evaluation clinique du céfotaxime à différents dosages thérapeutiques dans les infections urinaires. Nouvelle Presse Médicale 1981, 10: 625–627.

    Google Scholar 

  8. Guibert, J., Coppens, H., Yvelin, C.: Evaluation clinique du céfotiam dans les infections urinaires de l'adulte. Pathologie et Biologie 1982, 30: 353–356.

    PubMed  Google Scholar 

  9. Guibert, J., Acar, J. F., Miegi, M.: Evaluation clinique de l'azthréonam dans les infections urinaires sévères. Pathologie et Biologie 1984, 32: 446–449.

    PubMed  Google Scholar 

  10. Guibert, J., Acar, J. F., Destrée, D., Bryskier, A.: Evaluation clinique de la cefmenoxime dans les infections urinaires et prostatiques. Pathologie et Biologie 1985, 33: 330–334.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Clinical Microbiology, Hospital Saint-Joseph, Université Pierre et Marie Curie, 7 Rue Pierre Larousse, 75674, Paris Cedex 14, France

    J. Guibert, D. Destrée & J. Acar

  2. Clinical Research, Bayer Pharma France, 49-51 Quai de Dion Bouton, 92806, Puteaux, France

    C. Konopka

Authors
  1. J. Guibert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Destrée
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Konopka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Acar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guibert, J., Destrée, D., Konopka, C. et al. Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria. Eur. J, Clin. Microbiol. 5, 247–248 (1986). https://doi.org/10.1007/BF02014000

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02014000

Keywords

Search

Navigation